Karen L. Smith Insider Trading $JAZZ Jazz Pharmaceuticals plc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karen L. Smith.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karen L. Smith. Karen L. Smith is Director in ANTARES PHARMA, INC. ($ATRS) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and EVP, R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and Global Head of R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and Director in ACCELERON PHARMA INC ($XLRN) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and EVP, Chief Medical Officer in Emergent BioSolutions Inc. ($EBS).

Karen L. Smith in Jazz Pharmaceuticals plc

Trading Symbol: JAZZ
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: EVP, R&D and CMO, Global Head of R&D and CMO
Holdings: 28,474 shares
Current Value: $3,560,674
Latest Transaction: Mar 07 2018
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Karen L. Smith in Jazz Pharmaceuticals plc

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, XLRN, ATRS, EBS, JAZZ, SGMO, SCMP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 07 2018	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Payment of Exercise	F	143.39	648	92,917	28,474	29.1 K to 28.5 K (-2.23 %)
Mar 05 2018	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Option Exercise	A	140.67	19,290	2,713,524	19,290
Mar 05 2018	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Option Exercise	A	140.67	710	99,876	710
Mar 05 2018	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Grant	A	0.00	8,000	0	29,122	21.1 K to 29.1 K (+37.88 %)
May 12 2017	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Option Exercise	A	155.18	2,500	387,950	2,500
May 12 2017	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Grant	A	0.00	1,000	0	21,527	20.5 K to 21.5 K (+4.87 %)
May 12 2017	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	EVP, R&D and CMO	Payment of Exercise	F	155.18	641	99,470	20,527	21.2 K to 20.5 K (-3.03 %)
Mar 06 2017	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Option Exercise	A	136.18	17,848	2,430,541	17,848
Mar 06 2017	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Option Exercise	A	136.18	902	122,834	902
Mar 06 2017	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Grant	A	0.00	7,500	0	21,168	13.7 K to 21.2 K (+54.87 %)
Aug 12 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Buy	P	137.26	1	137	14,182	14.2 K to 14.2 K (+0.01 %)
Aug 12 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Buy	P	137.10	607	83,218	14,181	13.6 K to 14.2 K (+4.47 %)
Jul 13 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Buy	P	143.63	580	83,305	13,574	13 K to 13.6 K (+4.46 %)
Jun 15 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Buy	P	149.61	557	83,335	12,994	12.4 K to 13 K (+4.48 %)
May 12 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Payment of Exercise	F	148.76	641	95,355	12,399	13 K to 12.4 K (-4.92 %)
Feb 29 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Option Exercise	A	123.36	14,375	1,773,300	14,375
Feb 29 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Option Exercise	A	123.36	625	77,100	625
Feb 29 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Grant	A	0.00	6,000	0	13,143	7.1 K to 13.1 K (+84.00 %)
Apr 15 2016	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Payment of Exercise	F	147.34	103	15,176	13,040	13.1 K to 13 K (-0.78 %)
May 13 2015	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Option Exercise	A	176.51	15,516	2,738,729	15,516
May 13 2015	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Option Exercise	A	176.51	2,264	399,619	2,264
May 13 2015	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Grant	A	0.00	275	0	7,105	6.8 K to 7.1 K (+4.03 %)
May 13 2015	JAZZ	Jazz Pharmaceutica ...	Smith Karen L.	Global Head of R&D ...	Grant	A	0.00	6,830	0	6,830	0 to 6.8 K

Page: 1